Sweden: Borcherding replaces Matthieu as CEO at Immunovia

Immunovia, a blood-based diagnostic company, has named Jeff Borcherding as global CEO. Borcherding, until now president of the firm’s US operations replaces current CEO, Philipp Matthieu. The move marks the next step in the company focusing on the US market. Borcherding has led Immunovia’s US business since April 2022. Prior to joining Immunovia, he held…

You must be a HMI Subscriber to view this content.

Subscribe Now »